Risk-adapted Omission of Systematic Cores in PI-RADS 3 Lesions Based on Prostate-specific Antigen Density, Biopsy Route, and Targeted Core Number: A Multicentre Cohort Study

Overview of attention for article published in European Urology Oncology, July 2026

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (87th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 15 X users

Readers on

mendeley: 3 Mendeley

So far, Altmetric has seen 17 X posts from 15 X users, with an upper bound of 93,851 followers.

RT @UIowa_urology: New from Dr. James Brown and @MoAbouChakra in @EurUrolOncol: Risk-adapted Omission of Systematic Cores in PI-RADS 3 Lesi…

New from Dr. James Brown and @MoAbouChakra in @EurUrolOncol: Risk-adapted Omission of Systematic Cores in PI-RADS 3 Lesions Based on Prostate-specific Antigen Density, Biopsy Route, and Targeted Core Number: A Multicentre Cohort Study. https://t.co/CwBQ…

RT @APCCC_Lugano: Should systematic biopsy still be routine for every PI-RADS 3 lesion—or are we approaching an era of risk-adapted biopsy?…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 13 additional X posts.